Agrochemical

Status Quo of Pesticide Reevaluation in China

Pesticide reevaluation refers to the reassessment of a registered pesticide through safety, efficacy, and agronomic aspects, by using the latest scientific tools and findings. This procedure has been ...

2022-03-23

Cosmetic

China NIFDC Consults on Limitation of Benzene in Cosmetics

To strengthen the management of safety risk substances in cosmetics, on Mar. 10, 2022, China National Institutes for Food and Drug Control (NIFDC) released an announcement seeking public comments ...

2022-03-22

Disinfectant & Biocide

K-BPR: New Requirement for the Packaging and Advertising of Household Chemical Products and Biocidal Products

On February 10, 2022, the South Korean Ministry of Environment (MoE) issued the MoE Ordinance No.972 to announce amendments to the Enforcement Rules of the Act on Safety Management of Household ...

2022-03-22

Cosmetic

FAQs from NMPA on China Cosmetic Supervision and Administration

On March 10, 2022, China NMPA issued an announcement, answering frequently asked questions about cosmetic ingredient safety information, efficacy claim evaluation and sample retention. With the aim ...

2022-03-18

Industrial Chemical

Long-awaited India REACH to be Released in Months

According to insider sources, India’s Chemicals (Management & Safety) Rules (CMSR), which is dubbed “India REACH” will be notified to the WTO in May or June and took effect in August this year. ...

2022-03-17

Industrial Chemical

China MEE Adds 18 Substances into IECSC

On March 3, 2022, the Chinese Ministry of Ecology and Environment (MEE) published a notice, announcing the addition of 18 substances into the Inventory of Existing Chemical Substances (IECSC). These ...

2022-03-17

Pharmaceutical

Drug Application Fees for FY 2022 in China and the U.S.

In general, drug regulators charge fees from applicants to ensure the review of drug applications proceed efficiently. For drug applicants, the fees are legally bounded for acquiring or extending ...

2022-02-16

Pharmaceutical

Biogen's Rare Disease Drug Gets Access to More Patients in China Due to NRDL

In December 2021, Biogen cut the price of Spinraza (Nusinersen Sodium Injection) from 700,000 yuan per dose to 33,000 yuan per dose. The move was for getting a place in China's National Reimbursement ...

2022-02-16

Pharmaceutical

China Greenlights Online Sales of Prescription Drugs in Shenzhen

China officially permits Shenzhen to pilot the online sales of prescription drugs, according to the market-access-relaxing measures released by National Development and Reform Commission and the ...

2022-02-16

Industrial Chemical

New Hazchem Registration Online System to be Implemented Nationwide in 2022

On January 5, 2022, the Work Safety Committee of the State Council issued the National Plan for Centralized Management of Safety Risks of Hazardous Chemicals[1]. The plan proposes to enhance the ...

2022-01-17